Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07620613

Perinatal Mortality Outcomes Through Household Infection Pathways

The goal of this trial is to learn if replacing household soil floors with concrete floors can prevent deaths of infants around the time of birth, including stillbirths and deaths in the first month of life in rural Bangladesh. The primary question the study aims to answer is: Does residing in a home with a concrete vs. soil floor reduce the perinatal and neonatal morality in index children and their younger siblings up to 6 years post-installation of concrete floors?

Researchers will compare participants in households with concrete floors (intervention) vs. soil floors (comparison group) to see if concrete floors reduce the rate of perinatal death and child death up the 6 years post-intervention.

This study will extend an ongoing NIH-funded randomized trial in which households with soil floors where a pregnant woman resided were randomly chosen to receive a concrete floor intervention or to retain their existing soil floor. This study will track pregnancies, births, and deaths among infants born to pregnant mothers in the original study to measure effects of household concrete flooring up to 6 years after the concrete floors were installed.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

Up to 6 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

International Centre for Diarrhoeal Disease Research, Bangladesh

Dhaka, Bangladesh

Location contact

Md. Mahbubur Rahman, MBBS

PRINCIPAL_INVESTIGATOR

About this study

This study extends follow-up of an interventional, randomized controlled trial that enrolled 800 households in rural Bangladesh with soil floors where a pregnant woman resided and randomized them 1:1 to receive a concrete floor or keep their existing soil floor (Cement flooRs AnD chiLd hEalth (CRADLE), NCT05372068). The original trial installed concrete floors in the intervention arm during their pregnancy and will measure the primary endpoint when children born to enrolled pregnant women (i.e., index children) reach age 2 years. This study extends follow-up to up to 6 years after concrete floors were installed to measure perinatal and child mortality among all children born to CRADLE-enrolled mothers during the study period, including index children and children born in subsequent pregnancies. For subsequent pregnancies occurring during the study period, research staff will visit study homes in the perinatal period to ascertain birth outcomes and child deaths. For index children previously enrolled in the CRADLE trial, research staff will ascertain child deaths by phone once per year. For each death identified during the study period, research staff will perform verbal and social autopsy, and cause of death will be classified using the International Classification of Diseases, 11th Revision (ICD-11).

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Prior enrollment in the CRADLE trial (NCT05372068), in either arm, and currently residing in the original CRADLE-enrolled household
  • Residence in Sirajganj or Tangail districts in Bangladesh
  • No major non-compliance (e.g., no removal of concrete floor in intervention arm or installation of concrete floor in control arm)
  • No plan to relocate within the study follow-up period
  • Incident pregnancy occurring after CRADLE trial enrollment, confirmed after 26 weeks gestation

Treatment and study plan

Concrete household floor

Other

Household soil floors will be replaced with concrete floors

Primary outcomes

  1. Extended perinatal mortality rate

    Time frame: Up to 6 years post-intervention delivery in parent study

    Total number of stillbirths (babies born following fetal deaths at 22 weeks or later gestation) and neonatal deaths within the first 28 days after birth divided by the number of total births (live births + stillbirths)

Secondary outcomes

  1. Stillbirth rate

    Time frame: Up to 6 years post-intervention delivery in parent study

    Total number of stillbirths (babies born following fetal deaths at 22 weeks or later gestation) divided by the number of total births (live births + stillbirths)

  2. Early neonatal mortality rate

    Time frame: Up to 6 years post-intervention delivery in parent study

    Total number of deaths occurring in the first 7 days of life divided by the number of live births

  3. Neonatal mortality rate

    Time frame: Up to 6 years post-intervention delivery in parent study

    Total number of deaths occurring in the first 28 days of life divided by the number of live births

  4. Infant mortality rate

    Time frame: Up to 6 years post-intervention delivery in parent study

    Total deaths prior to age 12 months among live births divided by total live births

  5. Child mortality rate

    Time frame: Up to 6 years post-intervention delivery in parent study

    Total deaths at any age among live births divided by total live births

Sponsors and collaborators

Lead sponsor

Stanford University

Other

Collaborators

  • Directorate General of Health Services, Bangladesh
  • International Centre for Diarrhoeal Disease Research, Bangladesh
  • North Carolina State University
  • Thrasher Research Fund

Registry information

Official study title

Effect of Cement Floors on Perinatal and Neonatal Mortality in Bangladesh: a Randomized Trial in Rural Bangladesh

Acronym: POTH

Important dates

Study start
2026
Primary completion
2029
Study completion
2029
First posted
Jun 2, 2026
Registry last updated
Jul 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.